Epithelial-to-Mesenchymal Transition Enhances Cancer Cell Sensitivity to Cytotoxic Effects of Cold Atmospheric Plasmas in Breast and Bladder Cancer Systems
Cold atmospheric plasma (CAP) has emerged as a highly selective anticancer agent, most recently in the form of plasma-activated medium (PAM). Since epithelial–mesenchymal transition (EMT) has been implicated in resistance to various cancer therapies, we assessed whether EMT status is associated with...
Main Authors: | Peiyu Wang, Renwu Zhou, Patrick Thomas, Liqian Zhao, Rusen Zhou, Susmita Mandal, Mohit Kumar Jolly, Derek J. Richard, Bernd H. A. Rehm, Kostya (Ken) Ostrikov, Xiaofeng Dai, Elizabeth D. Williams, Erik W. Thompson |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-06-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/12/2889 |
Similar Items
-
Plasma‐activated medium triggers immunomodulation and autophagic activity for periodontal regeneration
by: Shengfang Wang, et al.
Published: (2023-07-01) -
Plasma medicine for neuroscience—an introduction
by: Xu Yan, et al.
Published: (2019-10-01) -
Plasma-Treated Solutions (PTS) in Cancer Therapy
by: Hiromasa Tanaka, et al.
Published: (2021-04-01) -
Bactericidal Silver Nanoparticles by Atmospheric Pressure Solution Plasma Processing
by: Janith Weerasinghe, et al.
Published: (2020-05-01) -
Cold Atmospheric Plasma Medicine: Applications, Challenges, and Opportunities for Predictive Control
by: Ali Kazemi, et al.
Published: (2024-03-01)